IDT Australia Limited (ASX:IDT)

Market Cap	38.67M
Revenue (ttm)	18.77M
Net Income (ttm)	-4.80M
Shares Out	429.68M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	82,818
Average Volume	178,682
Open	0.0990
Previous Close	0.0950
Day's Range	0.0900 - 0.0990
52-Week Range	0.0800 - 0.1450
Beta	1.11
RSI	41.43
Earnings Date	Aug 26, 2025

About IDT Australia

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services. The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provid...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1975
• Employees: 100
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDT

Financial Performance

In 2024, IDT Australia's revenue was 14.02 million, an increase of 100.67% compared to the previous year's 6.99 million. Losses were -5.41 million, -36.30% less than in 2023.